Divi's Laboratories Q3 Results
- BSE: 532488
- NSE: DIVISLAB
- ISIN: INE361B01024
- Sector: Biotechnology & Drugs
BSE
8,495.00
-5.00 (-0.06%)
-5.00 (-0.06%)Volume23.18 K
Updated: Mon 17 Aug, 2026 | 15:28:19
NSE
8,481.50
4.50 (0.05%)
4.50 (0.05%)Volume2.52 L
Updated: Mon 17 Aug, 2026 | 15:50:07
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Divi's Laboratories Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,906.00 | 1,721.00 | -1.75% | 1,461.00 | 13.79% |
| Depreciation/ Amortization | 118.00 | 99.00 | 4.42% | 95.00 | 19.19% |
| Operating Income | 698.00 | 617.00 | -9.94% | 394.00 | 8.39% |
| Net Income | 583.00 | 510.00 | -15.38% | 358.00 | -1.02% |
| Other Operating Expenses Total | 402.00 | 349.00 | 0.50% | 369.00 | 12.61% |
| Net Income Before Taxes | 780.00 | 722.00 | -14.47% | 489.00 | 7.44% |
| Total Revenue | 2,604.00 | 2,338.00 | -4.09% | 1,855.00 | 12.29% |
| Selling/ General/ Admin Expenses Total | 367.00 | 304.00 | 3.67% | 268.00 | 23.57% |
| Diluted Normalized EPS | 24.07 | 19.20 | -7.33% | 13.50 | 8.40% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.